Company: BIAF
Filing Date: 2025-04-15
Form Type: PRE 14A
Source: 0001641172-25-004857
Chunk: 79

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-15
Form: PRE 14A
Chunk 79
---
 issued in connection with our private placement offering that closed          
 on February 26, 2025, that may be equal to or exceed 20% of our Common Stock outstanding before such offering (the “Warrant           
 Exercise Proposal”).                                                                                                                  |

<div align='center'>FOR ☐AGAINST ☐ABSTAIN ☐</div>

| 5. | Proposal                                                                                                                          
 to consider and approve an adjournment of the Annual Meeting to a later date, if necessary or appropriate, to permit              
 further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the 
 approval of the Reverse Stock Split Proposal or the Warrant Exercise Proposal (the “Adjournment Proposal”).                       |

<div align='center'>FOR ☐AGAINST ☐ABSTAIN ☐</div>

| In their discretion, the Proxies are authorized                                                                                                                   
 to vote upon such other matters as may properly come before the meeting or any adjournment thereof. Any of the Proxies, or their respective                       
 substitutes, who shall be present and acting at the Annual Meeting shall have and may exercise all the powers hereby granted.                                     |
| The undersigned acknowledges receipt of our 2024 Annual Report to Stockholders, Notice of Annual Meeting of Stockholders and the Proxy Statement related thereto. |
| Please sign exactly as your name(s) appear(s)                                                                                                                     
 hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each                           
 sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized                          
 officer.                                                                                                                                                          |
| ______________________________________                                                                                                                            |
| Signature                                                    Date                                                                                                 |
| ______________________________________                                                                                                                            |
| Signature (Joint Owners)                           Date                                                                                                           |

<div align='center'>Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:The Notice and Proxy Statement and Annual Report are available at www.proxyvote.com</div>

<div align='center'>bioAffinity Technologies, Inc.

Annual Meeting of Stockholders

June 6, 2025, 8:00 a.m. Central Time

This proxy card is solicited on behalf of the Board of Directors.</div>

Maria Zannes and James Michael Edwards, or any
of them, each with the power of substitution, are hereby authorized to represent as proxies and vote with respect to the proposals set
forth on the reverse side and, in the discretion